Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

A Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patients with Higher Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Disease Sites: Myelodysplastic Syndrome

Phase: I/II

Investigator: Kishtagari, Ashwin

NCTID: NCT04417517

Protocol No: VICCHEMP2084

An Open-Label, Multicenter, Randomized Phase 3 Study of First-Line Encorafenib Plus Cetuximab with or without Chemotherapy versus Standard of Care Therapy with a Safety Lead-In of Encorafenib and Cetuximab Plus Chemotherapy In Participants with Metastatic BRAF V600e-Mutant Colorectal Cancer

Multiple Cancer Types

Disease Sites: Colon, Rectal

Phase: III

Investigator: Eng, Cathy

NCTID: NCT04607421

Protocol No: VICCGI2085

A Multicenter Phase Ib Trial for Patients with Advanced Hematologic Malignancies undergoing Allogeneic Hematopoietic Cell Transplantation with TregGraft, a T-cell-Depleted Graft with Additional Infusion of Conventional T cells and Regulatory T cells

Multiple Cancer Types

Disease Sites: Leukemia, Myelodysplastic Syndrome, Phase I

Phase: I

Investigator: Dholaria, Bhagirathbhai

NCTID: NCT04013685

Protocol No: VICCCTTP2086

JHMIRB: Prospective Clinical Study of the Relationship Between Cancer Driving Mutations Found in Endometriotic Implants and Development of Progesterone Resistance

Gynecologic

Disease Sites: Gynecologic

Phase: N/A

Investigator: Tran, Kaylon

NCTID:

Protocol No: VICCGYN2091

GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC Patients

Multiple Cancer Types

Disease Sites: Lung, Non Small Cell

Phase: II

Investigator: Maldonado, Fabien

NCTID: NCT04495153

Protocol No: VICCTHO2094

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

Head/Neck

Disease Sites: Head/Neck

Phase: II/III

Investigator: Topf, Michael

NCTID: NCT04333537

Protocol No: NRGHN006

Phase 1/2, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ALVR106 in Addition to Standard of Care for the Treatment of High-Risk Patients with Respiratory Viral Infections After Hematopoietic Cell or Solid Organ Transplant

Hematologic

Disease Sites: Hematologic

Phase: I/II

Investigator: Dholaria, Bhagirathbhai

NCTID: NCT04933968

Protocol No: VICCCTT2098

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Nave Metastatic Pancreatic Cancer (GIANT)

Pancreatic

Disease Sites: Pancreatic

Phase: II

Investigator: Cardin, Dana

NCTID: NCT04233866

Protocol No: ECOGGIEA2186

Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response

Pancreatic

Disease Sites: Pancreatic

Phase: N/A

Investigator: Xu, Junzhong

NCTID: NCT04588025

Protocol No: VICCGI2099

An Open-Label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with MK-6482 and Lenvatinib (MK-7902), or MK-1308A in Combination with Lenvatinib, versus Pembrolizumab and Lenvatinib, as Firstline Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Kidney (Renal Cell)

Disease Sites: Kidney (Renal Cell)

Phase: III

Investigator: Beckermann, Kathryn

NCTID: NCT04736706

Protocol No: VICCURO20101

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)